Frederick C. Beddingfield III Net Worth & Insider Trades

Frederick C. Beddingfield III - President & CEO, Sienna Biopharmaceuticals, Inc

As of August 8, 2019

What is Frederick C. Beddingfield III's Net Worth?

The current estimated net worth of Sienna Biopharmaceuticals, Inc's President & CEO, Frederick C. Beddingfield III, is estimated to be about $12.34M . Frederick C. Beddingfield III owns about 944,276 units of Sienna Biopharmaceuticals, Inc common stock. In the last 2 years at Sienna Biopharmaceuticals, Inc, Frederick C. Beddingfield III has sold an estimated value of $12.97K worth.

What is Frederick C. Beddingfield III's Past Insider Trading?

Frederick C. Beddingfield III's largest purchase order was 40,000 units , worth over $100K on February 26, 2019. In total, Frederick C. Beddingfield III has made about 8 transactions over 2 years of their time at Sienna Biopharmaceuticals, Inc. Frederick C. Beddingfield III usually trades in August and July, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Frederick C. Beddingfield III's' Mailing Address?

  • Mailing address is C/o Kythera Biopharmaceuticals, Inc. 27200 West Agoura Road, Suite 200 Calabasas CA 91301 CA

What are Sienna Biopharmaceuticals, Inc's Past Insider Trades?

Sienna Biopharmaceuticals, Inc's most recent insider trade came on February 26, 2019 by Arch Venture Partners X Llc, Arch Venture Fund X Overage Lp, Arch Venture Partners X Overage Lp, Keith Crandell, Robert Nelsen and Steven Gillis who bought 2,165,800 units worth $5.41M . In the last 2 years, insiders at Sienna Biopharmaceuticals, Inc have sold an estimated value of $1.71M and bought an estimated value of $17.81M worth of shares. Insider trading is most common in June and August, with the busiest year in 2019. The most active traders at the company are Todd Harris,  Frederick C. Beddingfield III, President & CEO,  and Paul F Lizzul, Chief Medical Officer .

Sienna Biopharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1